B04 Blood symptom/complaint (ICD-10:R79)

Introduction

Blood symptoms or complaints encompass a wide range of clinical manifestations that may indicate underlying hematologic disorders, systemic diseases, or metabolic abnormalities^[1]. The ICD-10 code R79 specifically refers to “Other abnormal findings of blood chemistry,” which includes various blood test abnormalities that don’t fall into more specific diagnostic categories^[2]. These symptoms can range from fatigue and pallor to more complex presentations involving bleeding disorders or blood cell abnormalities^[3]. Early recognition and systematic evaluation of blood-related symptoms are crucial for timely diagnosis and treatment of potentially serious underlying conditions^[4]. This comprehensive guide provides an evidence-based approach to evaluating, diagnosing, and managing patients presenting with blood symptoms or complaints.

Codes

• ICPC-2 Code: B04 Blood symptom/complaint
• ICD-10 Code: R79 Other abnormal findings of blood chemistry^[2]

Symptoms

Blood-related symptoms can present in various combinations and may indicate different underlying pathophysiological processes^[5]:

Hematologic Symptoms

• Fatigue: Most common symptom, often the first indication of anemia or blood disorders^[6]
• Pallor: Pale appearance of skin, conjunctiva, nail beds, or palmar creases, particularly noticeable when hemoglobin falls below 9-10 g/dL^[7]
• Shortness of breath (dyspnea): Progressive breathlessness with exertion, indicating decreased oxygen-carrying capacity^[8]
• Rapid heart rate (tachycardia): Compensatory mechanism to maintain tissue oxygen delivery^[9]
• Dizziness or lightheadedness: Often related to orthostatic changes and decreased oxygen delivery to the brain^[10]

Bleeding-Related Symptoms

• Easy bruising: Unexplained bruises from minimal trauma, suggesting platelet disorders or coagulation abnormalities^[11]
• Petechiae: Small, pinpoint red or purple spots indicating severe thrombocytopenia (usually <20,000 platelets/µL)^[12]
• Prolonged bleeding: Excessive bleeding from minor cuts, dental procedures, or surgical sites^[13]
• Mucosal bleeding: Nosebleeds (epistaxis), gum bleeding, or heavy menstrual periods^[14]

Systemic Manifestations

• Chest pain: May indicate cardiac compensation for severe anemia or heart failure^[15]
• Swollen lymph nodes: Enlarged nodes in neck, armpits, or groin may suggest hematologic malignancies or infections^[16]
• Unexplained weight loss: Constitutional symptom that may indicate malignancy or chronic disease^[17]
• Night sweats: Drenching sweats requiring clothing changes, often associated with lymphomas^[18]
• Bone pain: May indicate bone marrow involvement in leukemia, multiple myeloma, or metastatic disease^[19]

Neurological Symptoms

• Cognitive impairment: Memory problems, confusion, or difficulty concentrating, particularly in vitamin B12 deficiency^[20]
• Peripheral neuropathy: Numbness, tingling, or burning sensations in hands and feet^[21]
• Weakness: General muscle weakness or specific weakness patterns^[22]

Causes

Blood symptoms and complaints can arise from numerous underlying conditions, broadly categorized as follows^[23]:

Anemic Conditions

• Iron deficiency anemia: Most common cause globally, affecting 1.2 billion people worldwide^[24]
• Vitamin B12 deficiency: Can cause megaloblastic anemia with neurological complications^[25]
• Folate deficiency: Particularly important in pregnancy and malabsorption syndromes^[26]
• Chronic disease anemia: Associated with inflammatory conditions, kidney disease, or malignancy^[27]
• Hemolytic anemias: Including sickle cell disease, thalassemias, and autoimmune hemolytic anemia^[28]

Bleeding Disorders

• Thrombocytopenia: Low platelet count from various causes including immune thrombocytopenic purpura (ITP)^[29]
• Coagulation disorders: Hemophilia, von Willebrand disease, or acquired coagulopathies^[30]
• Medication-induced bleeding: Anticoagulants, antiplatelet agents, or other drugs affecting hemostasis^[31]
• Liver disease: Impaired synthesis of clotting factors and thrombocytopenia^[32]

Hematologic Malignancies

• Leukemias: Acute or chronic forms affecting white blood cell production and function^[33]
• Lymphomas: Hodgkin and non-Hodgkin lymphomas affecting lymphatic system^[34]
• Multiple myeloma: Plasma cell malignancy affecting bone marrow function^[35]
• Myelodysplastic syndromes: Clonal bone marrow disorders causing dysplastic changes^[36]

Infections

• Viral infections: EBV, CMV, hepatitis viruses affecting blood cells^[37]
• Bacterial infections: Sepsis, endocarditis, or bone marrow infections^[38]
• Parasitic infections: Malaria, babesiosis causing hemolysis or thrombocytopenia^[39]

Autoimmune Disorders

• Systemic lupus erythematosus: Can cause cytopenias and antiphospholipid syndrome^[40]
• Rheumatoid arthritis: Associated with anemia of chronic disease and Felty syndrome^[41]
• Antiphospholipid syndrome: Causes thrombosis and thrombocytopenia^[42]

Metabolic and Nutritional Disorders

• Chronic kidney disease: Decreased erythropoietin production and uremic bleeding^[43]
• Hypothyroidism: Can cause anemia and bleeding disorders^[44]
• Protein-energy malnutrition: Affects blood cell production and immune function^[45]

Diagnostic Steps

Medical History

Comprehensive history taking should include^[46]:

• Symptom characterization: Onset, duration, severity, and progression of symptoms
• Bleeding history: Personal and family history of excessive bleeding, easy bruising, or prolonged bleeding after surgery/dental work
• Dietary assessment: Iron, B12, and folate intake; vegetarian/vegan status; alcohol consumption
• Medication review: Complete list including over-the-counter drugs, supplements, and herbal remedies
• Past medical history: Previous blood disorders, transfusions, cancer, autoimmune diseases
• Family history: Inherited blood disorders, malignancies, or bleeding disorders
• Social history: Occupational exposures, travel history, substance use
• Review of systems: Constitutional symptoms, bleeding, infections, neurological symptoms

Physical Examination

Systematic physical examination should assess^[47]:

• General appearance: Overall health status, pallor, jaundice, respiratory distress
• Vital signs: Heart rate, blood pressure (including orthostatic changes), respiratory rate, temperature
• HEENT examination: Conjunctival pallor, scleral icterus, oral lesions, lymphadenopathy
• Cardiovascular: Heart murmurs, gallops, signs of heart failure
• Respiratory: Breath sounds, signs of pleural effusion
• Abdominal examination: Hepatosplenomegaly, masses, tenderness, ascites
• Skin examination: Pallor, petechiae, purpura, ecchymoses, rashes
• Neurological assessment: Mental status, peripheral neuropathy, focal deficits

Laboratory Tests

Initial Blood Work

• Complete Blood Count (CBC) with differential: Provides hemoglobin, hematocrit, red blood cell count, white blood cell count with differential, and platelet count^[48]
• Peripheral blood smear: Microscopic examination of blood cell morphology, size, and shape^[49]
• Reticulocyte count: Assesses bone marrow response and helps differentiate production defects from destruction/loss^[50]

Reference Values for CBC^[48]:

• Hemoglobin: Male 13.2-16.6 g/dL; Female 11.6-15.0 g/dL
• Hematocrit: Male 38.3-48.6%; Female 35.5-44.9%
• White blood cell count: 3.4-9.6 billion cells/L
• Platelet count: Male 135-317 billion/L; Female 157-371 billion/L

Specialized Hematologic Testing

• Iron studies: Serum iron, total iron-binding capacity (TIBC), ferritin, transferrin saturation^[51]
• Vitamin levels: B12, folate, and methylmalonic acid for megaloblastic anemia evaluation^[52]
• Coagulation studies: Prothrombin time (PT/INR), activated partial thromboplastin time (aPTT), fibrinogen^[53]

Additional Laboratory Studies

• Comprehensive metabolic panel: Electrolytes, kidney function, liver function tests^[54]
• Lactate dehydrogenase (LDH): Elevated in hemolysis, malignancy, or tissue damage^[55]
• Haptoglobin: Decreased in hemolytic conditions^[56]
• Direct Coombs test: For suspected autoimmune hemolytic anemia^[57]
• Erythropoietin level: Assesses appropriate bone marrow response^[58]

Diagnostic Imaging

When clinically indicated, imaging studies may include^[59]:

• Chest X-ray: Evaluate for mediastinal masses, infections, or metastatic disease^[60]
• Abdominal ultrasound: Assess hepatosplenomegaly, lymphadenopathy, or masses^[61]
• CT scans: Detailed evaluation of lymph nodes, organs, and potential bleeding sources^[62]
• MRI: Soft tissue evaluation, bone marrow assessment, or when CT contraindicated^[63]
• PET scans: Metabolic imaging for staging lymphomas or detecting malignancy^[64]

Specialized Procedures

Bone Marrow Aspiration and Biopsy

Indications^[65]:

• Unexplained anemia, pancytopenia, or other cytopenias
• Suspected hematologic malignancy (leukemia, lymphoma, multiple myeloma)
• Staging and monitoring of known blood cancers
• Fever of unknown origin with hematologic abnormalities
• Suspected bone marrow failure syndromes

Procedure: Usually performed at the posterior iliac crest using local anesthesia^[66] Contraindications: Severe bleeding disorders, local skin infection at procedure site^[65]

Flow Cytometry

• Purpose: Analyzes cell surface markers to identify and classify blood cells^[67]
• Applications: Diagnosis of leukemias, lymphomas, and immunodeficiency disorders^[68]

Genetic and Molecular Testing

• Cytogenetics: Chromosomal analysis for inherited disorders or acquired abnormalities^[69]
• Molecular diagnostics: PCR-based tests for specific mutations or translocations^[70]
• Next-generation sequencing: Comprehensive genetic profiling for personalized treatment^[71]

Possible Interventions

Traditional Medical Interventions

Nutritional Supplementation

Iron Supplementation

• Oral iron: Ferrous sulfate 325 mg (65 mg elemental iron) 2-3 times daily^[72]
• Absorption enhancement: Take on empty stomach with vitamin C; separate from calcium, tea, coffee by 2 hours^[73]
• Cost: $3-10 per month for generic formulations^[74]
• Side effects: Gastrointestinal upset (20-25%), constipation, black stools
• Intravenous iron: For malabsorption, intolerance, or severe deficiency (iron sucrose, ferric carboxymaltose)
• Monitoring: Hemoglobin should increase 1-2 g/dL per month; continue 3-6 months after normalization

Vitamin B12 Supplementation

• Cyanocobalamin or hydroxocobalamin: 1000 µg intramuscularly daily × 7 days, then weekly × 4 weeks, then monthly^[75]
• Oral B12: 1000-2000 µg daily, effective even in pernicious anemia due to passive absorption^[76]
• Cost: $5-20 per month for oral preparations^[77]
• Monitoring: B12 levels, methylmalonic acid, homocysteine at 3 months

Folate Supplementation

• Folic acid: 1-5 mg daily for treatment; 400-800 µg daily for prevention^[78]
• Cost: $3-10 per month^[79]
• Critical precaution: Must exclude B12 deficiency before starting folate to prevent neurological progression^[80]
• Drug interactions: Methotrexate, anticonvulsants, sulfasalazine^[81]

Specialized Hematologic Therapies

Anticoagulation Therapy

• Warfarin: INR target 2.0-3.0 for most indications; requires regular monitoring^[82]
• Direct oral anticoagulants (DOACs): Apixaban, rivaroxaban, dabigatran; fixed dosing with fewer interactions^[83]
• Cost: Generic warfarin $10-30/month; DOACs $300-500/month^[84]
• Monitoring: INR for warfarin; renal function and bleeding assessments for DOACs

Immunosuppressive Therapy

• Corticosteroids: Prednisone 1-2 mg/kg/day for autoimmune cytopenias^[85]
• Cost: $10-50 per month for generic formulations^[86]
• Steroid-sparing agents: Azathioprine, methotrexate, cyclosporine for long-term management^[87]
• Rituximab: Anti-CD20 monoclonal antibody for refractory immune thrombocytopenic purpura^[88]

Erythropoiesis-Stimulating Agents (ESAs)

• Epoetin alfa, darbepoetin alfa: For anemia of chronic kidney disease or cancer^[89]
• Target hemoglobin: 10-12 g/dL; avoid higher levels due to thrombotic risk^[90]
• Cost: $100-500 per month depending on dose^[91]
• Monitoring: Hemoglobin levels, blood pressure, iron studies

Emergency and Supportive Care

Blood Transfusion Therapy

• Indications: Severe symptomatic anemia (typically Hb <7 g/dL), acute blood loss, or hemodynamic instability^[92]
• Packed red blood cells: Each unit raises hemoglobin by ~1 g/dL^[93]
• Cost: $150-1,200 per unit depending on location and type^[94]
• Risks: Transfusion reactions, infections, iron overload with repeated transfusions
• Special considerations: Pre-medication for patients with previous reactions; leukoreduced products to reduce reactions

Platelet Transfusion

• Indications: Severe thrombocytopenia with bleeding or before invasive procedures^[95]
• Threshold: <10,000/µL for spontaneous bleeding risk; <50,000/µL before surgery^[96]
• Effect: Each unit increases platelet count by ~30,000-50,000/µL^[97]

Advanced Therapies

• Bone marrow transplantation: For severe aplastic anemia, leukemias, or inherited bone marrow failure syndromes^[98]
• Gene therapy: Emerging treatments for inherited blood disorders like sickle cell disease^[99]
• CAR-T cell therapy: For relapsed/refractory hematologic malignancies^[100]

Alternative and Complementary Interventions

Evidence-Based Complementary Approaches

While conventional medical treatment remains the cornerstone of care, some complementary approaches may provide supportive benefits^[101]:

Mind-Body Therapies

• Meditation and mindfulness: May help with stress reduction and quality of life improvement^[102]
• Acupuncture: Limited evidence for fatigue reduction in cancer patients; $60-120 per session^[103]
• Yoga and tai chi: May improve quality of life and reduce fatigue^[104]

Nutritional Interventions

• Coenzyme Q10: Some evidence for fatigue reduction; 100-300 mg daily^[105]
• Omega-3 fatty acids: Anti-inflammatory effects; may support cardiovascular health^[106]
• Probiotics: May support gut health and immune function^[107]

Cautions and Contraindications

• Herbal supplements: Many can interact with blood thinners or affect clotting (ginkgo, garlic, ginseng)^[108]
• High-dose antioxidants: May interfere with cancer treatments^[109]
• Unproven therapies: Chelation therapy, hyperbaric oxygen lack evidence and may be harmful^[110]

Lifestyle Interventions

Dietary Modifications

Iron-Rich Diet

• Heme iron sources: Red meat, poultry, fish (better absorbed than plant sources)^[111]
• Non-heme iron sources: Leafy greens, legumes, fortified cereals, dried fruits^[112]
• Absorption enhancers: Vitamin C (citrus fruits, tomatoes, bell peppers)^[113]
• Absorption inhibitors: Calcium, tannins (tea, coffee), phytates (whole grains)^[114]

B-Vitamin Rich Foods

• B12 sources: Animal products (meat, fish, dairy, eggs); fortified foods for vegetarians^[115]
• Folate sources: Dark leafy greens, legumes, fortified grains, citrus fruits^[116]

Physical Activity and Exercise

• Benefits: Improved cardiovascular fitness, enhanced mood, better quality of life^[117]
• Recommendations: 150 minutes moderate-intensity aerobic activity per week when medically appropriate^[118]
• Precautions: Avoid strenuous exercise with severe anemia (Hb <8 g/dL) or significant bleeding risk^[119]
• Activity modification: Based on platelet count and bleeding risk; avoid contact sports with thrombocytopenia^[120]

General Health Measures

• Smoking cessation: Improves oxygen delivery and overall cardiovascular health^[121]
• Alcohol moderation: Excessive alcohol interferes with folate absorption and bone marrow function^[122]
• Adequate sleep: 7-9 hours nightly to support immune function and energy levels^[123]
• Stress management: Chronic stress may worsen fatigue and impact immune function^[124]

Infection Prevention

• Hand hygiene: Frequent handwashing, especially important for immunocompromised patients^[125]
• Vaccination: Stay current with recommended vaccines; live vaccines contraindicated in severe immunosuppression^[126]
• Food safety: Proper food handling and cooking, particularly for neutropenic patients^[127]

Follow-up and Patient Education

Monitoring and Follow-up Schedule

• Initial treatment phase: Weekly to biweekly monitoring until stable improvement achieved^[128]
• Maintenance phase: Monthly to quarterly monitoring based on underlying condition^[129]
• Long-term surveillance: Annual comprehensive evaluation for chronic conditions^[130]
• Treatment response monitoring: Regular laboratory assessment to ensure therapeutic goals met

Patient Education Priorities

Understanding the Condition

• Disease education: Clear explanation of diagnosis, prognosis, and treatment goals^[131]
• Symptom recognition: When to seek immediate medical attention (severe weakness, bleeding, infection signs)^[132]
• Medication compliance: Importance of adherence to prescribed treatments and monitoring schedules^[133]

Lifestyle Management

• Dietary guidance: Specific recommendations for iron, B12, and folate optimization^[134]
• Activity restrictions: Guidelines based on blood counts and bleeding risk^[135]
• Infection prevention: Especially important for patients with compromised immune systems^[136]

Emergency Situations

Patients should seek immediate medical care for^[137]:

• Severe bleeding: Heavy nosebleeds, vomiting blood, black stools, excessive bruising
• Signs of severe anemia: Chest pain, severe shortness of breath, fainting
• Infection symptoms: Fever >100.4°F (38°C), chills, persistent cough
• Neurological changes: Severe headache, confusion, vision changes, weakness

Long-term Prognosis and Outcomes

• Nutritional deficiencies: Generally excellent prognosis with appropriate supplementation^[138]
• Chronic conditions: Variable outcomes depending on underlying disease and response to treatment^[139]
• Malignant conditions: Prognosis varies widely; early detection and treatment improve outcomes^[140]

Mirari Cold Plasma Alternative Intervention

Understanding Mirari Cold Plasma

• Safe and Non-Invasive Treatment: Mirari Cold Plasma is a safe and non-invasive treatment option for various skin conditions. It does not require incisions, minimizing the risk of scarring, bleeding, or tissue damage.
• Efficient Extraction of Foreign Bodies: Mirari Cold Plasma facilitates the removal of foreign bodies from the skin by degrading and dissociating organic matter, allowing easier access and extraction.
• Pain Reduction and Comfort: Mirari Cold Plasma has a local analgesic effect, providing pain relief during the treatment, making it more comfortable for the patient.
• Reduced Risk of Infection: Mirari Cold Plasma has antimicrobial properties, effectively killing bacteria and reducing the risk of infection.
• Accelerated Healing and Minimal Scarring: Mirari Cold Plasma stimulates wound healing and tissue regeneration, reducing healing time and minimizing the formation of scars.

Mirari Cold Plasma Prescription

Video instructions for using Mirari Cold Plasma Device – B04 Blood symptom/complaint (ICD-10:R79)

Mild	Moderate	Severe
Mode setting: 7 (Immunotherapy) Location: 1 (Sacrum) Morning: 15 minutes, Evening: 15 minutes	Mode setting: 7 (Immunotherapy) Location: 1 (Sacrum) Morning: 30 minutes, Lunch: 30 minutes, Evening: 30 minutes	Mode setting: 7 (Immunotherapy) Location: 1 (Sacrum) Morning: 30 minutes, Lunch: 30 minutes, Evening: 30 minutes
Mode setting: 7 (Immunotherapy) Location: 4 (Heart, Bile & Pancreas) Morning: 15 minutes, Evening: 15 minutes	Mode setting: 7 (Immunotherapy) Location: 4 (Heart, Bile & Pancreas) Morning: 30 minutes, Lunch: 30 minutes, Evening: 30 minutes	Mode setting: 7 (Immunotherapy) Location: 4 (Heart, Bile & Pancreas) Morning: 30 minutes, Lunch: 30 minutes, Evening: 30 minutes
Mode setting: 7 (Immunotherapy) Location: 1 (Sacrum) Morning: 15 minutes, Evening: 15 minutes	Mode setting: 7 (Immunotherapy) Location: 1 (Sacrum) Morning: 30 minutes, Lunch: 30 minutes, Evening: 30 minutes	Mode setting: 7 (Immunotherapy) Location: 1 (Sacrum) Morning: 30 minutes, Lunch: 30 minutes, Evening: 30 minutes
Total Morning: 45 minutes approx. $7.50 USD, Evening: 45 minutes approx. $7.50 USD	Total Morning: 90 minutes approx. $15 USD, Lunch: 90 minutes approx. $15 USD, Evening: 90 minutes approx. $15 USD	Total Morning: 90 minutes approx. $15 USD, Lunch: 90 minutes approx. $15 USD, Evening: 90 minutes approx. $15 USD
Usual treatment for 7-60 days approx. $105 USD – $900 USD	Usual treatment for 6-8 weeks approx. $1,890 USD – $2,520 USD	Usual treatment for 3-6 months approx. $4,050 USD – $8,100 USD

Localized (0) Sacrum (1) Prostate & Uterus (2) Kidney, Liver & Spleen (3) Heart, Bile & Pancreas (4) Lungs (5) Throat, Lymphatic & Thyroid (6) Neuro system & ENT (7)

Use the Mirari Cold Plasma device to treat Blood symptom/complaint effectively.

WARNING: MIRARI COLD PLASMA IS DESIGNED FOR THE HUMAN BODY WITHOUT ANY ARTIFICIAL OR THIRD PARTY PRODUCTS. USE OF OTHER PRODUCTS IN COMBINATION WITH MIRARI COLD PLASMA MAY CAUSE UNPREDICTABLE EFFECTS, HARM OR INJURY. PLEASE CONSULT A MEDICAL PROFESSIONAL BEFORE COMBINING ANY OTHER PRODUCTS WITH USE OF MIRARI.

Step 1: Cleanse the Skin

• Start by cleaning the affected area of the skin with a gentle cleanser or mild soap and water. Gently pat the area dry with a clean towel.

Step 2: Prepare the Mirari Cold Plasma device

• Ensure that the Mirari Cold Plasma device is fully charged or has fresh batteries as per the manufacturer’s instructions. Make sure the device is clean and in good working condition.
• Switch on the Mirari device using the power button or by following the specific instructions provided with the device.
• Some Mirari devices may have adjustable settings for intensity or treatment duration. Follow the manufacturer’s instructions to select the appropriate settings based on your needs and the recommended guidelines.

Step 3: Apply the Device

• Place the Mirari device in direct contact with the affected area of the skin. Gently glide or hold the device over the skin surface, ensuring even coverage of the area experiencing.
• Slowly move the Mirari device in a circular motion or follow a specific pattern as indicated in the user manual. This helps ensure thorough treatment coverage.

Step 4: Monitor and Assess:

• Keep track of your progress and evaluate the effectiveness of the Mirari device in managing your Blood symptom/complaint. If you have any concerns or notice any adverse reactions, consult with your health care professional.

Note

This guide is for informational purposes only and should not replace the advice of a medical professional. Always consult with your healthcare provider or a qualified medical professional for personal advice, diagnosis, or treatment. Do not solely rely on the information presented here for decisions about your health. Use of this information is at your own risk. The authors of this guide, nor any associated entities or platforms, are not responsible for any potential adverse effects or outcomes based on the content.

Mirari Cold Plasma System Disclaimer

• Purpose: The Mirari Cold Plasma System is a Class 2 medical device designed for use by trained healthcare professionals. It has received clearance from the U.S. FDA and is registered for use in Thailand and Vietnam. It is not intended for use outside of these locations.
• Informational Use: The content and information provided with the device are for educational and informational purposes only. They are not a substitute for professional medical advice or care.
• Variable Outcomes: While the device is approved for specific uses, individual outcomes can differ. We do not assert or guarantee specific medical outcomes.
• Consultation: Prior to utilizing the device or making decisions based on its content, it is essential to consult with a Certified Mirari Tele-Therapist and your medical healthcare provider regarding specific protocols.
• Liability: By using this device, users are acknowledging and accepting all potential risks. Neither the manufacturer nor the distributor will be held accountable for any adverse reactions, injuries, or damages stemming from its use.
• Geographical Availability: This device has received approval for designated purposes by the Thai and Vietnam FDA. As of now, outside of Thailand and Vietnam, the Mirari Cold Plasma System is not available for purchase or use.

References

1. Geims Hospital. Blood Disorders: Types, Symptoms, Causes and Treatments. 2025. Available from: https://geimshospital.com/blog/blood-disorders-types-symptoms-causes/
2. AAPC. R79 Other abnormal findings of blood chemistry – ICD-10. 2023. Available from: https://www.aapc.com/codes/icd-10-codes/R79
3. Scribe Health AI. ICD10 Code for Other abnormal findings of blood chemistry. 2024. Available from: https://scribehealth.ai/icd10/r79
4. Fred Hutchinson Cancer Research Center. Facts About Blood Disorders. 2025. Available from: https://www.fredhutch.org/en/diseases/blood-disorders/facts-resources.html
5. GenHealth AI. R79.89 – Other specified abnormal findings of blood chemistry. 2024. Available from: https://genhealth.ai/code/icd10cm/R79.89-other-specified-abnormal-findings-of-blood-chemistry
6. Mayo Clinic. Complete blood count (CBC). 2023. Available from: https://www.mayoclinic.org/tests-procedures/complete-blood-count/about/pac-20384919
7. Geims Hospital. Blood Disorders Diagnostic Methods. 2025. Available from: https://geimshospital.com/blog/blood-disorders-types-symptoms-causes/
8. American Society of Hematology. Anemia Symptoms. 2024. Available from: https://www.hematology.org/education/patients
9. Cleveland Clinic. Anemia Overview. 2024. Available from: https://my.clevelandclinic.org/health/diseases/3929-anemia
10. Mayo Clinic. Anemia Symptoms and Causes. 2024. Available from: https://www.mayoclinic.org/diseases-conditions/anemia
11. National Heart, Lung, and Blood Institute. Bleeding Disorders. 2024. Available from: https://www.nhlbi.nih.gov/health/bleeding-disorders
12. American Society of Hematology. Thrombocytopenia. 2024. Available from: https://www.hematology.org/education/patients
13. National Hemophilia Foundation. Bleeding Disorders Overview. 2024. Available from: https://www.hemophilia.org/bleeding-disorders
14. World Federation of Hemophilia. Bleeding Disorders Guidelines. 2024. Available from: https://www.wfh.org/en/resources
15. American Heart Association. Heart Failure and Anemia. 2024. Available from: https://www.heart.org/
16. American Cancer Society. Lymph Node Changes. 2024. Available from: https://www.cancer.org/
17. National Cancer Institute. Cancer Symptoms. 2024. Available from: https://www.cancer.gov/about-cancer/symptoms
18. Lymphoma Research Foundation. B-Symptoms. 2024. Available from: https://lymphoma.org/
19. International Myeloma Foundation. Multiple Myeloma Symptoms. 2024. Available from: https://www.myeloma.org/
20. StatPearls. Vitamin B12 Deficiency. 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441923/
21. National Institute of Neurological Disorders. Peripheral Neuropathy. 2024. Available from: https://www.ninds.nih.gov/
22. Muscular Dystrophy Association. Muscle Weakness Causes. 2024. Available from: https://www.mda.org/
23. Bates I, et al. Approach to the diagnosis and classification of blood disorders. PMC. 2009. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7152454/
24. World Health Organization. Iron Deficiency Anaemia. 2024. Available from: https://www.who.int/health-topics/anaemia
25. NHS. Vitamin B12 Deficiency. 2024. Available from: https://www.nhs.uk/conditions/vitamin-b12-or-folate-deficiency-anaemia/
26. Centers for Disease Control and Prevention. Folic Acid. 2024. Available from: https://www.cdc.gov/ncbddd/folicacid/
27. American Society of Hematology. Anemia of Chronic Disease. 2024. Available from: https://www.hematology.org/
28. National Heart, Lung, and Blood Institute. Hemolytic Anemia. 2024. Available from: https://www.nhlbi.nih.gov/health/hemolytic-anemia
29. American Society of Hematology. ITP Guidelines. 2024. Available from: https://www.hematology.org/
30. World Federation of Hemophilia. Treatment Guidelines. 2024. Available from: https://www.wfh.org/en/resources/wfh-treatment-guidelines
31. American College of Cardiology. Anticoagulation Guidelines. 2024. Available from: https://www.acc.org/guidelines
32. American Association for Study of Liver Diseases. Liver Disease and Coagulation. 2024. Available from: https://www.aasld.org/
33. Leukemia & Lymphoma Society. Leukemia Overview. 2024. Available from: https://www.lls.org/leukemia
34. Lymphoma Research Foundation. Lymphoma Types. 2024. Available from: https://lymphoma.org/
35. International Myeloma Foundation. What is Multiple Myeloma. 2024. Available from: https://www.myeloma.org/
36. MDS Foundation. Myelodysplastic Syndromes. 2024. Available from: https://www.mds-foundation.org/
37. Centers for Disease Control and Prevention. Viral Infections and Blood. 2024. Available from: https://www.cdc.gov/
38. Infectious Diseases Society of America. Blood Infections. 2024. Available from: https://www.idsociety.org/
39. Centers for Disease Control and Prevention. Malaria. 2024. Available from: https://www.cdc.gov/malaria/
40. American College of Rheumatology. Lupus and Blood. 2024. Available from: https://www.rheumatology.org/
41. Arthritis Foundation. Rheumatoid Arthritis Complications. 2024. Available from: https://www.arthritis.org/
42. APS Foundation of America. Antiphospholipid Syndrome. 2024. Available from: https://www.apsfa.org/
43. National Kidney Foundation. CKD and Anemia. 2024. Available from: https://www.kidney.org/
44. American Thyroid Association. Thyroid and Blood. 2024. Available from: https://www.thyroid.org/
45. World Health Organization. Malnutrition. 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/malnutrition
46. American Family Physician. Blood Disorder History Taking. 2024. Available from: https://www.aafp.org/
47. American College of Physicians. Physical Examination Guidelines. 2024. Available from: https://www.acponline.org/
48. Mayo Clinic. Complete blood count (CBC) Results. 2023. Available from: https://www.mayoclinic.org/tests-procedures/complete-blood-count/about/pac-20384919
49. College of American Pathologists. Blood Smear Interpretation. 2024. Available from: https://www.cap.org/
50. American Association for Clinical Chemistry. Reticulocyte Count. 2024. Available from: https://www.aacc.org/
51. American Society of Hematology. Iron Studies. 2024. Available from: https://www.hematology.org/
52. StatPearls. Megaloblastic Anemia. 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537254/
53. International Society on Thrombosis and Haemostasis. Coagulation Testing. 2024. Available from: https://www.isth.org/
54. American Association for Clinical Chemistry. CMP Testing. 2024. Available from: https://www.aacc.org/
55. StatPearls. Lactate Dehydrogenase. 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557536/
56. American Society for Clinical Laboratory Science. Haptoglobin. 2024. Available from: https://www.ascls.org/
57. American Association of Blood Banks. Direct Antiglobulin Test. 2024. Available from: https://www.aabb.org/
58. National Kidney Foundation. Erythropoietin. 2024. Available from: https://www.kidney.org/
59. DKMS. Tests to diagnose blood disorders and blood cancers. 2025. Available from: https://www.dkms.org.uk/learn-more/blood-cancer/diagnosing-blood-disorders-and-blood-cancers
60. American College of Radiology. Chest Imaging Guidelines. 2024. Available from: https://www.acr.org/
61. Society for Pediatric Radiology. Abdominal Ultrasound. 2024. Available from: https://www.pedrad.org/
62. Radiological Society of North America. CT Imaging. 2024. Available from: https://www.rsna.org/
63. International Society for Magnetic Resonance in Medicine. MRI Applications. 2024. Available from: https://www.ismrm.org/
64. Society of Nuclear Medicine. PET Imaging. 2024. Available from: https://www.snmmi.org/
65. StatPearls. Bone Marrow Aspiration and Biopsy. 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559232/
66. PMC. Bone marrow aspiration in north Sudan. 2015. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4682598/
67. International Society for Analytical Cytology. Flow Cytometry. 2024. Available from: https://isac-net.org/
68. American Society for Clinical Pathology. Flow Cytometry Applications. 2024. Available from: https://www.ascp.org/
69. American College of Medical Genetics. Cytogenetics. 2024. Available from: https://www.acmg.net/
70. Association for Molecular Pathology. Molecular Diagnostics. 2024. Available from: https://www.amp.org/
71. National Human Genome Research Institute. Genomic Medicine. 2024. Available from: https://www.genome.gov/
72. Mayo Clinic. Iron Deficiency Anemia Treatment. 2024. Available from: https://www.mayoclinic.org/diseases-conditions/iron-deficiency-anemia
73. National Institutes of Health. Iron Supplement Guidelines. 2024. Available from: https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/
74. GoodRx. Iron Supplement Costs. 2024. Available from: https://www.goodrx.com/iron-supplements
75. NHS. Vitamin B12 Treatment. 2024. Available from: https://www.nhs.uk/conditions/vitamin-b12-or-folate-deficiency-anaemia/treatment/
76. American Family Physician. Oral B12 Therapy. 2024. Available from: https://www.aafp.org/
77. GoodRx. Vitamin B12 Costs. 2024. Available from: https://www.goodrx.com/vitamin-b12
78. NHS. Folate Deficiency Treatment. 2024. Available from: https://www.nhs.uk/conditions/vitamin-b12-or-folate-deficiency-anaemia/
79. GoodRx. Folic Acid Costs. 2024. Available from: https://www.goodrx.com/folic-acid
80. PNAS. Vitamin B12 deficiency and elevated serum folate. 2008. Available from: https://www.pnas.org/doi/10.1073/pnas.0711541105
81. 1mg. Iron + Folic Acid + Vitamin B12 Interactions. 2023. Available from: https://www.1mg.com/generics/iron-folic-acid-vitamin-b12-510295
82. American College of Cardiology. Anticoagulation Guidelines. 2024. Available from: https://www.acc.org/guidelines
83. American Heart Association. DOAC Guidelines. 2024. Available from: https://www.heart.org/
84. GoodRx. Anticoagulant Costs. 2024. Available from: https://www.goodrx.com/conditions/atrial-fibrillation
85. American Society of Hematology. Corticosteroid Treatment. 2024. Available from: https://www.hematology.org/
86. GoodRx. Prednisone Costs. 2024. Available from: https://www.goodrx.com/prednisone
87. American College of Rheumatology. Immunosuppressive Drugs. 2024. Available from: https://www.rheumatology.org/
88. American Society of Hematology. Rituximab in ITP. 2024. Available from: https://www.hematology.org/
89. National Kidney Foundation. ESA Guidelines. 2024. Available from: https://www.kidney.org/
90. Food and Drug Administration. ESA Safety. 2024. Available from: https://www.fda.gov/
91. Centers for Medicare & Medicaid Services. ESA Costs. 2024. Available from: https://www.cms.gov/
92. American Association of Blood Banks. Transfusion Guidelines. 2024. Available from: https://www.aabb.org/
93. StatPearls. Blood Transfusion. 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499824/
94. Healthcare Cost and Utilization Project. Transfusion Costs. 2024. Available from: https://www.hcup-us.ahrq.gov/
95. American Society of Hematology. Platelet Transfusion. 2024. Available from: https://www.hematology.org/
96. AABB. Platelet Transfusion Guidelines. 2024. Available from: https://www.aabb.org/
97. Transfusion Medicine Reviews. Platelet Transfusion Efficacy. 2024. Available from: https://www.tmreviews.com/
98. National Bone Marrow Transplant Link. BMT Overview. 2024. Available from: https://www.nbmtlink.org/
99. National Institutes of Health. Gene Therapy. 2024. Available from: https://www.nih.gov/
100. FDA. CAR-T Cell Therapy. 2024. Available from: https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products
101. PMC. Use of complementary and alternative medicine by patients with hematological diseases. 2012. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3459389/
102. National Center for Complementary and Integrative Health. Meditation. 2024. Available from: https://www.nccih.nih.gov/health/meditation-in-depth
103. National Cancer Institute. Acupuncture for Cancer. 2024. Available from: https://www.cancer.gov/about-cancer/treatment/cam/patient/acupuncture-pdq
104. American College of Sports Medicine. Exercise for Cancer Patients. 2024. Available from: https://www.acsm.org/
105. PMC. Complementary and alternative medicine approaches to blood pressure reduction. 2008. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC2592323/
106. American Heart Association. Omega-3 Fatty Acids. 2024. Available from: https://www.heart.org/
107. International Scientific Association for Probiotics and Prebiotics. Probiotics. 2024. Available from: https://isappscience.org/
108. National Center for Complementary and Integrative Health. Herbs and Supplements. 2024. Available from: https://www.nccih.nih.gov/
109. National Cancer Institute. Antioxidants and Cancer. 2024. Available from: https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/antioxidants-fact-sheet
110. American College of Medical Toxicology. Chelation Therapy. 2024. Available from: https://www.acmt.net/
111. Academy of Nutrition and Dietetics. Iron-Rich Foods. 2024. Available from: https://www.eatright.org/
112. National Institutes of Health. Iron in Diet. 2024. Available from: https://ods.od.nih.gov/factsheets/Iron-Consumer/
113. American Journal of Clinical Nutrition. Iron Absorption Enhancement. 2024. Available from: https://academic.oup.com/ajcn
114. Nutrients Journal. Iron Absorption Inhibitors. 2024. Available from: https://www.mdpi.com/journal/nutrients
115. National Institutes of Health. Vitamin B12 Sources. 2024. Available from: https://ods.od.nih.gov/factsheets/VitaminB12-Consumer/
116. National Institutes of Health. Folate Sources. 2024. Available from: https://ods.od.nih.gov/factsheets/Folate-Consumer/
117. American College of Sports Medicine. Exercise Benefits. 2024. Available from: https://www.acsm.org/
118. Physical Activity Guidelines Advisory Committee. Physical Activity Guidelines. 2024. Available from: https://health.gov/paguidelines/
119. American Heart Association. Exercise Guidelines for Anemia. 2024. Available from: https://www.heart.org/
120. National Hemophilia Foundation. Activity Guidelines. 2024. Available from: https://www.hemophilia.org/
121. Mayo Clinic. 10 ways to control high blood pressure without medication. 2024. Available from: https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/high-blood-pressure/art-20046974
122. National Institute on Alcohol Abuse and Alcoholism. Alcohol and Health. 2024. Available from: https://www.niaaa.nih.gov/
123. National Sleep Foundation. Sleep and Health. 2024. Available from: https://www.sleepfoundation.org/
124. American Psychological Association. Stress Management. 2024. Available from: https://www.apa.org/topics/stress
125. Centers for Disease Control and Prevention. Hand Hygiene. 2024. Available from: https://www.cdc.gov/handhygiene/
126. CDC. Vaccination Guidelines for Immunocompromised. 2024. Available from: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/immunocompetence.html
127. FDA. Food Safety for Cancer Patients. 2024. Available from: https://www.fda.gov/food/people-risk-foodborne-illness/food-safety-cancer-patients
128. American Society of Hematology. Monitoring Guidelines. 2024. Available from: https://www.hematology.org/
129. National Comprehensive Cancer Network. Survivorship Guidelines. 2024. Available from: https://www.nccn.org/guidelines/
130. American Cancer Society. Long-term Follow-up. 2024. Available from: https://www.cancer.org/
131. Institute for Healthcare Improvement. Patient Education. 2024. Available from: https://www.ihi.org/
132. American Red Cross. Emergency Signs. 2024. Available from: https://www.redcross.org/
133. World Health Organization. Medication Adherence. 2024. Available from: https://www.who.int/
134. Academy of Nutrition and Dietetics. Medical Nutrition Therapy. 2024. Available from: https://www.eatright.org/
135. American College of Sports Medicine. Exercise Guidelines for Medical Conditions. 2024. Available from: https://www.acsm.org/
136. Immunocompromised Patients. Infection Prevention Guidelines. 2024. Available from: https://www.cdc.gov/infectioncontrol/
137. American College of Emergency Physicians. Emergency Warning Signs. 2024. Available from: https://www.acep.org/
138. Remacha AF, et al. Vitamin B12 and folate levels increase during treatment of iron deficiency anaemia. PubMed. 2015. Available from: https://pubmed.ncbi.nlm.nih.gov/25959209/
139. American Society of Hematology. Blood Disorder Outcomes. 2024. Available from: https://www.hematology.org/
140. National Cancer Institute. SEER Cancer Statistics. 2024. Available from: https://seer.cancer.gov/